HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Giovanoli, O. Articles by Ledermann, H. P. Search for Related Content PubMed PubMed Citation Articles by Giovanoli, O. Articles by Ledermann, H. P. Social Bookmarking                      What's this? Hotlight (NEW!) What's Hotlight?

MRI of Hepatic Adenomatosis: Initial Observations with Gadoxetic Acid Contrast Agent in Three Patients

¹ Department of Radiology, University Hospital Basel, Basel, Switzerland.
² Present address: Institute of Radiology, Kantonsspital Aarau, Tellstrasse, 5001 Aarau, Switzerland.
³ Department of Gastroenterology, University Hospital Basel, Basel, Switzerland.
⁴ Department of Pathology, University Hospital Basel, Basel, Switzerland.
⁵ Imamed Radiologie Nordwest, Basel, Switzerland.

OBJECTIVE. The purpose of our study was to describe the MR signal characteristics of histologically proven liver adenomatosis in three patients using gadoxetic acid, a newly developed liver-specific MR contrast agent.

CONCLUSION. In all three patients, more than 100 liver adenomas revealed no metabolism of the new liver-specific contrast agent in the delayed phase. Because of absent or strongly reduced intracellular uptake of gadoxetic acid in all adenomas during delayed contrast-enhanced series, differentiation of adenomas from dysplastic or malignant lesions was not possible.

Keywords: abdominal imaging • gadoxetic acid • liver adenomatosis • liver imaging

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?